BAMCO Inc’s Revolution Medicines RVMD Stock Holding History

BAMCO Inc’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Buy	12,500 +10,000	+400%	+$1.46M	﹤0.01%	279
2026 Q1	$243K	Buy	+2,500	New	+$252K	﹤0.01%	318

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BAMCO Inc's RVMD Position: Q2 2026 in Review

BAMCO Inc increased its Revolution Medicines (RVMD) stake by 400% in Q2 2026, buying an estimated $1.46M and bringing the position to 12,500 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #279.

BAMCO Inc first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

BAMCO Inc held 12,500 shares of Revolution Medicines worth $2.34M as of Q2 2026.
BAMCO Inc bought 10,000 Revolution Medicines shares in Q2 2026, an estimated $1.46M.
Revolution Medicines made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #279 holding.
BAMCO Inc first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.